NO973875L - Fremgangsmåte for stimulering av en immunrespons - Google Patents

Fremgangsmåte for stimulering av en immunrespons

Info

Publication number
NO973875L
NO973875L NO973875A NO973875A NO973875L NO 973875 L NO973875 L NO 973875L NO 973875 A NO973875 A NO 973875A NO 973875 A NO973875 A NO 973875A NO 973875 L NO973875 L NO 973875L
Authority
NO
Norway
Prior art keywords
immune response
stimulating
individuals
monovclonal
pathogenic
Prior art date
Application number
NO973875A
Other languages
English (en)
Norwegian (no)
Other versions
NO973875D0 (no
Inventor
Mark Alderson
Kim A Campbell
Mary K Kennedy
Charles R Maliszewski
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of NO973875D0 publication Critical patent/NO973875D0/no
Publication of NO973875L publication Critical patent/NO973875L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO973875A 1995-03-01 1997-08-22 Fremgangsmåte for stimulering av en immunrespons NO973875L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39623095A 1995-03-01 1995-03-01
PCT/US1996/002839 WO1996026735A1 (en) 1995-03-01 1996-02-29 Method for stimulating an immune response

Publications (2)

Publication Number Publication Date
NO973875D0 NO973875D0 (no) 1997-08-22
NO973875L true NO973875L (no) 1997-10-31

Family

ID=23566398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973875A NO973875L (no) 1995-03-01 1997-08-22 Fremgangsmåte for stimulering av en immunrespons

Country Status (15)

Country Link
EP (1) EP0812206B1 (de)
JP (1) JP3657271B2 (de)
KR (1) KR19980702490A (de)
AT (1) ATE220331T1 (de)
AU (1) AU699291B2 (de)
CA (1) CA2213798C (de)
DE (1) DE69622259T2 (de)
DK (1) DK0812206T3 (de)
ES (1) ES2179187T3 (de)
FI (1) FI973484L (de)
MX (1) MX9706588A (de)
NO (1) NO973875L (de)
NZ (1) NZ305083A (de)
PT (1) PT812206E (de)
WO (1) WO1996026735A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033406A4 (de) * 1997-10-27 2005-03-09 Sumitomo Electric Industries Induktor zur herstellung eines antigen-spezifischen antikörpers, expressionsvektor enthaltend ein hierfür entsprechendes gen, sowie verfahren zur induktion der herstellung eines antigen-spezifischen antikörpers
JP2001526241A (ja) * 1997-12-19 2001-12-18 イミュネックス・コーポレーション Ｈｉｖ感染に対する感受性を低下させるための方法
CN1762492A (zh) * 1998-05-23 2006-04-26 莱顿大学医学中心 Cd40结合分子和ctl肽在用于治疗肿瘤的药物组合物中的用途
US7371392B2 (en) 2000-02-02 2008-05-13 The United States Of America As Represented By The Department Of Health And Human Services Cd40 ligand adjuvant for respiratory syncytial virus
MY183797A (en) 2006-09-18 2021-03-16 Univ Arkansas Compositions and methods of enhancing immune responses
US9125854B2 (en) 2007-10-30 2015-09-08 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
BRPI0819229B1 (pt) 2007-11-01 2019-01-22 The Board Of Trustees Of The University Of Arkansas vacinas para reforçar reações imunes contra eimeria
NZ601609A (en) 2010-01-21 2014-08-29 Univ Arkansas Vaccine vectors and methods of enhancing immune responses
JP5746333B2 (ja) 2010-06-09 2015-07-08 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー カンピロバクター感染を減少させるワクチン及び方法
ES2709654T3 (es) 2011-04-29 2019-04-17 Apexigen Inc Anticuerpos anti-CD40 y métodos de uso
EP3925977A1 (de) 2012-10-30 2021-12-22 Apexigen, Inc. Anti-cd40-antikörper und verfahren zur verwendung
WO2014127185A1 (en) 2013-02-14 2014-08-21 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
MY173901A (en) 2013-03-15 2020-02-26 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to enteric pathogens
CN116196426A (zh) 2015-07-16 2023-06-02 百欧肯治疗有限公司 治疗癌症的组合物及方法
SG11201808821WA (en) 2016-04-18 2018-11-29 Celldex Therapeutics Inc Agonistic antibodies that bind human cd40 and uses thereof
AU2017260323B2 (en) 2016-05-03 2023-11-16 The Board Of Trustees Of The University Of Arkansas Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0667901B2 (de) * 1991-10-25 2008-10-15 Immunex Corporation Neue cytokine
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
JP3675819B2 (ja) * 1993-10-01 2005-07-27 イミュネックス・コーポレーション Ｃｄ４０に対する抗体

Also Published As

Publication number Publication date
FI973484A7 (fi) 1997-10-24
MX9706588A (es) 1997-11-29
KR19980702490A (ko) 1998-07-15
NO973875D0 (no) 1997-08-22
AU699291B2 (en) 1998-11-26
PT812206E (pt) 2002-11-29
CA2213798A1 (en) 1996-09-06
CA2213798C (en) 2001-02-06
WO1996026735A1 (en) 1996-09-06
JP3657271B2 (ja) 2005-06-08
FI973484L (fi) 1997-10-24
NZ305083A (en) 1999-06-29
FI973484A0 (fi) 1997-08-25
DE69622259T2 (de) 2003-03-27
AU5301196A (en) 1996-09-18
ES2179187T3 (es) 2003-01-16
ATE220331T1 (de) 2002-07-15
JPH11506418A (ja) 1999-06-08
EP0812206A1 (de) 1997-12-17
DK0812206T3 (da) 2002-09-09
DE69622259D1 (de) 2002-08-14
EP0812206B1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
NO973875L (no) Fremgangsmåte for stimulering av en immunrespons
ATE163195T1 (de) Lösliche liganden für cd40
DK0724456T3 (da) CD40-Antistoffer
DE69429925D1 (de) METHODE ZUR BINDUNG VON MATERIAL AN DAS Beta-AMYLOID-PEPTID
NO963168L (no) Immunstimulatoriske monoklonale antistoffer
FR2491334B1 (de)
DE58904713D1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
DE3874387D1 (de) Immunologische methoden und materialien zur bestimmung von tumor assoziierten antigenen.
AU1971295A (en) Humanized monoclonal antibodies against human interleukin-4
DE3684578D1 (de) Monoklonale antikoerper mit bindungsspezifitaet fuer menschliche prostatatumorantigene und methoden fuer ihre verwendung.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO930406L (no) Spesifikke antistoffer mot aktiverte blodplater samt fremstilling derav
NO952506L (no) Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker
MX9602274A (es) Procedimiento para la preservacion de antigenos sin usar inhibidores enzimaticos y su aplicacion en metodos inmunologicos.